UTime (WTO) outlined its ongoing exploration in the field of health data analysis, particularly the potential application of artificial intelligence technologies. UTime is developing AI-based algorithm models aimed at performing in-depth analysis of continuous physiological data collected from smart wearable devices such as watches and rings. Current research directions include: building hypertension risk assessment models by integrating multi-parameter data like blood pressure, heart rate, activity and sleep; and conducting trend assessments of users’ cardiovascular system health status by analyzing features such as pulse wave morphology. The company explicitly states that all these AI analysis functions are intended to provide users with health trend insights and risk management references and are not substitutes for professional medical diagnosis.
Claim 70% Off TipRanks This Holiday Season
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on WTO:
- UTime Limited Launches Innovative Smart Ring for Health Monitoring
- UTime releases smart ring product for health monitoring
- UTime Limited Unveils Smartwatch with Blood Pressure Monitoring
- UTime Limited Announces Extraordinary General Meeting for Share Consolidation
- UTime Limited Announces Strategic Shift with Elderly Care Platform Partnership
